ロード中...
Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
Neoantigens derive from non-synonymous somatic mutations in malignant cells. Recognition of neoantigens presented via human leukocyte antigen (HLA) molecules on the tumor cell surface by T cells holds promise to enable highly specific and effective anti-cancer immune responses and thus neoantigens p...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6934135/ https://ncbi.nlm.nih.gov/pubmed/31921218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.03004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|